金沙9001cc以诚为本|中国百科·品牌公司

师资

EN       返回上一级       师资搜索
陈金娜
研究副教授
chenjn@sustech.edu.cn

陈金娜,金沙9001cc以诚为本电子与电气工程系研究副教授,深圳市海外高层次人才, IEEE高级会员。从事精准化、智能化、个体化重大疾病诊疗技术交叉研究,主要面向重大疾病早期筛查、粘膜下肿瘤探查、术野导航及组织识别和精准内科等领域的多学科交叉研究,授权中国发明专利6项,科技成果转化一项,发表SCI论文52篇, H-Index 16,引用1089次。代表作发表在The BMJ, Nature Structural & Molecular Biology, Light: Science & Applications (高被引), Analytical Chemistry, ACS Applied Materials & Interfaces 等期刊。任中国光学学会生物医学光子学专业委员会委员、中国抗癌学会肿瘤节律专业委员会委员、PhotoniX Life 青年编委;担任IEEE全球光电大会生物医学光子学专题/特别分会主席四次。获2023 Photonics Global Conference (PGC)青年科学家奖;2018年中山大学“紫荆谷创新创业发展辅导中心”第三届创业策划大赛冠军。


教育背景

2011-2015 理学博士 香港大学 

2008-2011 理学硕士 中山大学

2004-2008 理学学士 华南理工大学 


工作经历

2023—至今  金沙9001cc以诚为本 电子与电气工程系 研究副教授

2021—2023  金沙9001cc以诚为本 电子与电气工程系 研究助理教授

2020—2020  金沙9001cc以诚为本 电子与电气工程系 高级研究学者

2015—2017  香港中文大学  威尔斯亲王医院  博士后


研究领域

面向重大疾病精准智能诊疗技术的多学科交叉研究

u 重大疾病早期筛查: 基于体液拉曼光谱探测芯片、装备及诊断算法

u 粘膜下肿瘤探查: 高分辨光学相干层析成像及功能超声多模内窥系统

u 术野导航及组织识别:  肿瘤边界组织拉曼高光谱成像装备及智能算法

u 个体化精准内科: 血药浓度定量技术及多模态疗效预测算法

 

代表文章

1. Minghui Niu; Chengwei Shan; Chenlong Xue; Xiaowei Xu; Aoyan Zhang; Yihong Xiao; Junyu Wei; Defeng Zou; Gina Jinna Chen*; Aung Ko Ko Kyaw*; Perry Ping Shum*; High-Stability Printable Perovskite SERS Substrates in an Aqueous Environment via Plasmon-Induced Resonance Energy Transfer, ACS Applied Materials & Interfaces, 2025, 17(0): 13538-13551.

2. Jiaqi Hu#; Chenlong Xue#; Ken Xiaokeng Chi#; Junyu Wei; Zhicheng Su; Qiuyue Chen; Ziyu Ou; Shuxin Chen; Zhe Huang; Yilin Xu; Haoyun Wei; Yanjun Liu; Perry Ping Shum*; Gina Jinna Chen*; Raman Spectral Feature Enhancement Framework for Complex Multiclassification Tasks, Analytical Chemistry, 2025, 97: 130-139.

3. Liu, Guo-Ying#; Ye, Yan-Fang#; Jiang, Yao-Fei#; Chen, Gina Jinna#; Xia, Wei-Xiong#; Huang, Yi-Sheng#; Gao, Tian-Sheng#; Liu, Yi-Min; Hou, Ya-Ting; Li, Jian-Fei; Liu, Jia-Hao; Lu, Nian; Chen, Chang-Long; Ke, Liang-Ru; Liang, Hu; Bei, Wei-Xin; Li, Wang-Zhong; Dong, Shu-Hui; Liu, Qin; Xie, Changqing; Yao, He-Rui; Xiang, Yan-Qun*; Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial, The BMJ-British Medical Journal, 2024, 385: e077890-10.

4. Chen, Junfan#; Hu, Jiaqi#; Xue, Chenlong#; Zhang, Qian; Li, Jingyan; Wang, Ziyue; Lv, Jinqian; Zhang, Aoyan; Dang, Hong; Lu, Dan; Zou, Defeng; Cong, Longqing; Li, Yuchao; Chen, Gina Jinna*; Shum, Perry Ping*; Combined Mutual Learning Net for Raman Spectral Microbial Strain Identification, Analytical Chemistry, 2024, 96(15): 5824-5831.

5. Jiaqi Hu#; Gina Jinna Chen#*; Chenlong Xue; Pei Liang; Yanqun Xiang; Chuanlun Zhang; XiaokengChi; Guoying Liu; Yanfang Ye; DongyuCui; DeZhang; Xiaojunyu; Hong Dang; Wen Zhang; Junfan Chen; Quan Tang; Penglai Guo; Ho-Pui Ho; Yuchao Li; Longqing Cong; Perry Ping Shum*; RSPSSL A novel high-fidelity Raman spectral preprocessing scheme to enhance biomedical applications and chemical resolution visualization, Light: Science & Applications, 2024, 13(52): 1-21.

6. Wei Zhang#; Zijian Zhang#; Yun Xiang#; Dong-Dong Gu#; Jinna Chen#; Yifan Chen; Shixian Zhai; Yong Liu; Tao Jiang; Chong Liu; Bin He; Min Yan; Zifeng Wang; Jie Xu; Yu-Lu Cao; Bing Deng; Deshun Zeng; Jie Lei; Junxiao Zhuo; Xinxing Lei; Zijie Long; Bilian Jin; Tongsheng Chen; Dong Li; Yidong Shen; Junjie Hu*; Song Gao*; Quentin Liu*; Aurora kinase A-mediated phosphorylation triggers structural alteration of Rab1A to enhance ER complexity during mitosis, Nature Structural & Molecular Biology, 2024, 31: 219-231.

XML 地图